Imprimis reports net loss in first quarter

Imprimis Pharmaceuticals reported a net loss of $3.5 million in the first quarter of 2018 compared with a net loss of $5 million in 2017’s first quarter, according to a press release.
Revenues for the quarter increased from $6.1 million in 2017 to $8.9 million this year, an increase of 45%.
Ophthalmology-related revenues were up 91% to $7 million.
General and administrative expenses were nearly unchanged at $6.5 million compared with $6.8 million a year ago.

Full Story →